Failure of the oxytocin-induced increase in secretion of urinary kallikrein in young spontaneously hypertensive rats

Japanese Journal of Pharmacology

Volumn 71, Issue 1, 1996, Pages 11-19

  Majima, Masataka ^a   Adachi, Keiichi ^a   Ohno, Takashi ^a   Ogino, Michiko ^a   Saito, Maki ^a   Kizuki, Kazuyuki ^b   Katsumata, Osamu ^a   Yamashina, Shohei ^a   Katori, Makoto ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Diuresis; Natriuresis; Oxytocin; Renal kallikrein; Spontaneously hypertensive rat

Indexed keywords

CREATININE; ICATIBANT; KALLIKREIN; OXYTOCIN; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIURESIS; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN URINE LEVEL; MALE; NATRIURESIS; NONHUMAN; POTASSIUM URINE LEVEL; RAT; SODIUM URINE LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; URINE VOLUME;

EID: 0029973781     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.11     Document Type: Article

References (37)

1. Elliot AH and Nuzum FR: The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18, 462 (1934)
2. Margolius HS, Geller R, Pisano J and Sjoerdsma A: Altered urinary kallikrein excretion in human hypertension. Lancet ii, 1063-1065 (1971)
3. Margolius HS, Horowitz D, Pisano JJ and Keiser HR: Urinary kallikrein excretion in hypertensive man: relationships to sodium intake and sodium-retaining steroids. Circ Res 35, 820-825 (1974)
4. Keiser HG, Geller RG, Margolius HS and Pisano JJ: Urinary kallikrein in hypertensive animal models. Fed Proc 35, 199-202 (1976)
5. Horowitz D, Margolius HS and Keiser HR: Effects of potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endcrinol Metab 47, 296-299 (1978)
6. Carretero OA, Plomski C, Hampton A and Scicli AG: Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin Exp Pharmacol Physiol 3, supp 55-59 (1976)
7. Gilboa N, Rudofsky U and Margo A: Urinary and renal kallikrein in hypertensive fawn-hooded (FH/Wjd) rats. Lab Invest 50, 72-78 (1984)
8. Ader JL, Pollocle DM, Butterfield MI and Arendshost WJ: Abnormalities in kallikrein excretion in spontaneously hypertensiverats. Am J Physiol 248, F396-F403 (1985)
9. Ader JL, Tran-Van T and Praddaude F: Reduced urinary kallikrein activity in rats developing spontaneous hypertension. Am J Physiol 252, F946-F969 (1987)
10. Praddaude F, Tran-Van T and Ader JL: Renal kallikrein activity in rats developing spontaneous hypertension. Clin Sci 176, 311-315 (1989)
11. Mohsin SSJ, Majima M, Katori M and Sharma JN: Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats. Asia Pacific J Pharmacol 7, 73-82 (1992)
12. Figueroa CD, Bhoola KD, MacIver AG and Mackenzie JC: An ontogenic study of renal tissue kallikrein on Okamoto spontaneously hypertensive rats: Comparisons with human hypertensive nephropathy. Nephrol Dial Transplant 7, 516-525 (1992)
13. Yasujima M, Abe K, Yanno M, Kohzuki M, Omata K, Kasai Y, Saito T, Takeuchi K, Itoh S, Kanazawa M, Hiwatari M, Saito T, Sato S and Yoshinaga K: Renal kallikrein activity in spontaneously hypertensive rats. J Hypertens 5, 687-692 (1987)
14. Leake RD, Weitzman RE, Glatz TH and Fisher DA: Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor. J Clin Endocrinol Metab 53, 730-733 (1981)
15. Adachi K, Majima M, Katori M and Nishijima M: Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized rats. Jpn J Pharmacol 67, 243-252 (1995)
16. Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T, Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin SSJ and Oh-ishi S: Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 17, 806-813 (1991)
17. Majima M, Yoshida O, Mihara H, Muto T, Mizogami S, Kuribayashi Y, Katori M and Oh-ishi S: High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22, 705-714 (1993)
18. Majima M, Mizogami S, Kuribayashi Y, Katori M and Oh-ishi S: Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24, 111-119 (1994)
19. Kizuki K, Kitagawa A, Takahashi H, Moriya H, Kudo M and Noguchi T: Immunohistochemical localization of kallikrein within the prolactin-producing cells of rat anterior pituitary gland. J Endocrinol 127, 317-323 (1990)
20. Takaoka M, Okamura H, Iwamoto T, Ikemoto C, Mimura Y and Morimoto S: Purification to apparent homogeneity of inactive kallikrein from rat urine. Biochem Biophys Res Commun 122, 1282-1288 (1984)
21. Kizuki K, Kamada M, Ikekita M and Moriya H: Porcine pancreatic prokallikrein. Chem Pharm Bull (Tokyo) 30, 3354-3361 (1982)
22. Adachi E, Kino J, Hayashi T, Sato Y and Hashimoto PH: The effect of fixatives and parafin embedding on the histochemical reactivity of a monoclonal antibody against human type IV collagen (JK-199). Arch Hist Cytol 52, 477-483 (1989)
23. Shoda T, Hatanaka K, Saito M, Majima M, Ogino M, Harada Y, Nishijima M, Katori M and Yamamoto S: Induction of cyclooxygenase type-2 (COX-2) in rat endometrium at the peak of serum estradiol during the esterus cycle. Jpn J Pharmacol 69, 289-291 (1995)
24. Vio CP and Figueroa CD: Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry. Kidney Int 28, 36-42 (1985)
25. Scicli AG, Carretero OA, Hampton A, Cortes P and Oza NB: Site of kininogenase secretion in the dog nephron. Am J Physiol 230, 533-536 (1976)
26. Margolius HS, Horowitz D, Geller RG, Alexander RW, Gill JR, Pisano JJ and Reiser HR: Urinary kallikrein excretion in normal man: relationships to sodium intake and sodium-retaining steroids. Circ Res 35, 812-819 (1974)
27. Geller RG, Margolius HS, Pisano JJ and Keiser HR: Effects of mineralocorticoids, altered sodium uptake and adrenalectomy on urinary kallikrein in rats. Circ Res 31, 857-861 (1972)
28. Bascands JL, Girolami J-P, Pecher C, Moatti J-P, Manuel Y and Suc JM: Compared effects of a low and high sodium diet on the renal and urinary concentration and activity of kallikrein in normal rats. J Hypertens 5, 311-315 (1987)
29. Katori M, Majima M, Mohsin SSJ, Hanazuka M and Mizogami S: Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats. Agents Actions 38, 235-242 (1992)
30. Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G and Margolius HS: Bartter's syndrome. Urinary prostaglandins E-like material and kallikrein; indomethacin effects. Ann Intern Med 87, 281-286 (1977)
31. Vio CP and Figueroa CD: Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int 31, 1327-1334 (1987)
32. Fejes-Toth G, Zahajszky T and Filep J: Effect of vasopressin on renal kallikrein excretion. Am J Physiol 239, F388-F392 (1980)
33. Stier CT, Manning M and Sawyer WH: Natriuretic effect of [7-glycine]oxytocinin the presence of diuretic agents in conscious rats. J Pharmacol Exp Ther 212, 412-417 (1980)
34. Garland HO, Balment RJ and Brimble MJ: Oxytocin and renal function in rat: An investigation of a possible proximal site of action. Acta Endocrinol 102, 517-520 (1983)
35. Habas P, Skopkova J, Zicha J, Barth T, Lebel M and Jost K: Nacartocin-analogue of oxytocin with enhanced natriuretic properties. Endocrinology 18, 117-124 (1984)
36. Tribollet E, Barberis C, Dreifuss JJ and Jard S: Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney. Kidney Int 33, 959-969 (1988)
37. Stoeckel ME and Freund-Mercier MJ: Autoradiographic demonstration of oxytocin-binding sites in the macula densa. Am J Physiol 257, F310-F314 (1989)